Raymond James analyst John Ransom maintained a Buy rating on Abbott Labs (NYSE: ABT) today and set a price target of $77. The company’s shares closed on Friday at $69.05, close to its 52-week high of $69.25.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 13.6% and a 67.2% success rate. Ransom covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Addus Homecare Corp, and LifePoint Health.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Labs with a $73.43 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $69.25 and a one-year low of $51.55. Currently, Abbott Labs has an average volume of 4.69M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
